2022
DOI: 10.1038/s41589-021-00958-5
|View full text |Cite
|
Sign up to set email alerts
|

XaaP-ing DPP8/9 for CARD8 activation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 9 publications
0
0
0
Order By: Relevance
“…Furthermore, unlike NLRP1, CARD8 binds to DPP9 outside of its catalytic pocket [ 66 ]. In contrast to talabostat, CQ31 is a selective CARD8 activator, inducing a weaker inhibition of DPP8/9 sufficient for release and activation of CARD8, but not NLRP1 [ 68 , 69 , 70 ]. Nevertheless, DPP8/9 represent a checkpoint for both inflammasome sensors.…”
Section: The Card8 Inflammasomementioning
confidence: 99%
“…Furthermore, unlike NLRP1, CARD8 binds to DPP9 outside of its catalytic pocket [ 66 ]. In contrast to talabostat, CQ31 is a selective CARD8 activator, inducing a weaker inhibition of DPP8/9 sufficient for release and activation of CARD8, but not NLRP1 [ 68 , 69 , 70 ]. Nevertheless, DPP8/9 represent a checkpoint for both inflammasome sensors.…”
Section: The Card8 Inflammasomementioning
confidence: 99%